Über uns
Xenios AG - a company of the Fresenius Medical Care Group - is a pioneer in extracorporeal heart and lung support. The Novalung and Medos products offer a wide range of heart and lung support products via a single platform, the Xenios console. Xenios' mission is to improve patient well-being and care. Novalung's ECMO therapy aims at a paradigm shift in lung support: Doctors gain time to treat the patient and at the same time the lungs have time to heal. Xenios AG has been part of Fresenius Medical Care, the world's leading provider of products and services for people with kidney disease since the end of 2016. Xenios complements the group's portfolio in the area of holistic multi-organ support of FME.
){kind=logo}